P523 Endoscopic balloon dilatation is safe and has a high success rate in patients with stricturing Crohn’s disease
E. Lim1,2,3, M. Thai2,4, P. Hendy2,4, M. Alchlaihawi5, R. Leong5,6,7, S. Connor6,8, W. Ng6,8, B. Gu6,8, D. van Langenberg9,10, L. Thin11,12, J. Schulberg13,14, M. Kamm13,14, R. Gilmore15, K. Taylor15, O. Sallis16,17, J. Andrews16,17, C. Daker18,19, M. Barclay18,19, G. Wark6,20, S. Ghaly6,20, M. Begun6, K. Krishnaprasad21, J. Begun*2,4,22
1Queen Elizabeth II Jubilee Hospital, Gastroenterology, Brisbane, Australia, 2The University Of Queensland, Faculty of Medicine, Brisbane, Australia, 3James Cook University, College of Medicine and Dentistry, Townsville, Australia, 4Mater Hospital Brisbane, Gastroenterology, Brisbane, Australia, 5Concord Repatriation General Hospital,, Sydney, Australia, 6University of New South Wales, Faculty of Medicine, Sydney, Australia, 7Macquarie University, Faculty of Medicine and Health Sciences, Sydney, Australia, 8Liverpool Hospital, Gastroenterology, Sydney, Australia, 9Eastern Health, Gastroenterology, Melbourne, Australia, 10Monash University, Faculty of Medicine, Nursing and Health Sciences, Melbourne, Australia, 11Fiona Stanley Hospital, Gastroenterology, Perth, Australia, 12University of Western Australia,, Faculty of Health and Medical Sciences, Perth, Australia, 13St Vincent’s Hospital, Gastroenterology, Melbourne, Australia, 14University of Melbourne, Faculty of Medicine, Dentistry and Health Sciences, Melbourne, Australia, 15The Alfred, Gastroenterology, Melbourne, Australia, 16Royal Adelaide Hospital, Gastroenterology, Adelaide, Australia, 17University of Adelaide, Faculty of Health and Medical Sciences, Adelaide, Australia, 18Christchurch Hospital, Gastroenterology, Christchurch, New Zealand, 19University of Otago, Department of Medicine, Christchurch, New Zealand, 20St Vincent’s Hospital, Gastroenterology, Sydney, Australia, 21QIMR Berghofer, Brisbane, Australia, 22Mater Research Institute - UQ, Brisbane, Australia
Stricturing Crohn’s disease (CD) is associated with significant morbidity and high rates of surgery with anastomotic strictures commonly occurring after surgery. Endoscopic balloon dilatation (EBD) may avoid or delay operative management of strictures.
A retrospective audit of CD patients undergoing EBD was conducted at 11 hospitals across Australia and New Zealand. Local, prospectively maintained patient databases and procedure records were used to identify cases from June 1999 to October 2018. A stricture was defined as a narrow segment of intestine unable to be traversed with a colonoscope. Stricture length (long ≥4 cm, short <4 cm), location (ileal, ileocolonic, colonic, anorectal) and type (anastomotic vs. de novo) were collected from endoscopy reports. Dates of surgeries and follow-up were obtained from medical records. Technical success was defined as the ability to traverse the stricture following dilatation. Baseline smoking status, Montreal phenotype and medications for CD were also documented.
A total of 236 patients with stricturing CD were identified (120 male, median age 48 [IQR: 10], 29% ileal, 12% colonic, 59% ileocolonic). A total of 620 dilatation procedures (303 for anastomotic strictures, 312 for de novo strictures, 5 unknown) were performed (median 2 per patient) with 428 (69%) on short strictures, 109 (18%) on long strictures, and 83 (13%) of unknown length. Balloon dilation diameter was 8 mm–20 mm (median 15 mm). Technical success was achieved in 433 (84%) of dilatations, and was significantly higher for short vs. long strictures (93% vs. 66%,
In one of the largest analyses of EBD for CD strictures, EBD is found to be a safe procedure with a high technical success rate overall. The highest success was observed in strictures less than 4 cm in length and non-ileal in location. EBD may be an effective strategy for avoiding surgery in stricturing Crohn’s disease and post-operative anastomotic strictures.